PMVP · PMV Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| ORBIMED ADVISORS LLC Director | ▼ Sell | Open Market | 4,975,291 Shares held | 10/23/2025 | View profile |
| Schroeder Thilo Director | ▼ Sell | Open Market | 1,101,283 Shares held | 10/6/2021 | View profile |
| David Henry Mack President and CEO | ▲ Buy | Option Exercise | 451,109 Shares held | 10/27/2025 | View profile |
| LEVINE ARNOLD J Director | ▼ Sell | Open Market | 409,842 Shares held | 9/22/2021 | View profile |
| Robert Ticktin General Counsel & COO | ▼ Sell | Open Market | 98,695 Shares held | 7/1/2025 | View profile |
| Deepika Jalota SVP, Regulatory Affairs and QA | ▼ Sell | Open Market | 89,959 Shares held | 7/1/2025 | View profile |
| Michael Carulli Chief Financial Officer | ▼ Sell | Open Market | 60,146 Shares held | 7/1/2025 | View profile |
| Leila Alland Chief Medical Officer | ▼ Sell | Open Market | 45,909 Shares held | 9/15/2023 | View profile |
| Winston Kung COO, CFO | ▼ Sell | Gift | 10,600 Shares held | 11/25/2022 | View profile |
Transaction History
| David Henry Mack | ▲ Buy | Option Exercise | 220,643 | $302K | 10/27/2025 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 1,000,000 | $1.5M | 10/23/2025 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 500,000 | $900K | 9/10/2025 |
| Robert Ticktin | ▼ Sell | Open Market | 23,151 | $25K | 7/1/2025 |
| Deepika Jalota | ▼ Sell | Open Market | 33,065 | $35K | 7/1/2025 |
| Michael Carulli | ▼ Sell | Open Market | 28,249 | $30K | 7/1/2025 |
| David Henry Mack | ▼ Sell | Open Market | 58,411 | $62K | 7/1/2025 |
| David Henry Mack | ▲ Buy | Option Exercise | 17,709 | $9K | 1/3/2025 |
| David Henry Mack | ▲ Buy | Option Exercise | 91,750 | $49K | 12/3/2024 |
| Deepika Jalota | ▼ Sell | Open Market | 7,218 | $11K | 9/11/2024 |
| Michael Carulli | ▼ Sell | Open Market | 2,891 | $4K | 9/11/2024 |
| Deepika Jalota | ▲ Buy | Grant | 95,555 | $0 | 1/18/2024 |
| Michael Carulli | ▲ Buy | Grant | 82,220 | $0 | 1/18/2024 |
| David Henry Mack | ▲ Buy | Grant | 163,890 | $0 | 1/18/2024 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 87,786 | $196K | 11/22/2023 |
| David Henry Mack | ▼ Sell | Gift | 85,307 | $0 | 11/10/2023 |
| David Henry Mack | ▼ Sell | Gift | 85,307 | $0 | 11/10/2023 |
| David Henry Mack | ▲ Buy | Option Exercise | 198,407 | $105K | 10/18/2023 |
| Leila Alland | ▼ Sell | Open Market | 6,291 | $42K | 9/15/2023 |
| Deepika Jalota | ▼ Sell | Open Market | 4,104 | $27K | 9/15/2023 |
| David Henry Mack | ▲ Buy | Option Exercise | 85,500 | $45K | 8/7/2023 |
| Winston Kung | ▼ Sell | Gift | 2,560 | $0 | 11/25/2022 |
| Deepika Jalota | ▲ Buy | Grant | 34,050 | $0 | 9/9/2022 |
| Leila Alland | ▲ Buy | Grant | 52,200 | $0 | 9/9/2022 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 26,253 | $418K | 5/26/2022 |
| David Henry Mack | ▲ Buy | Option Exercise | 33,000 | $17K | 4/27/2022 |
| Winston Kung | ▲ Buy | Option Exercise | 4,000 | $13K | 4/20/2022 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 34,500 | $730K | 3/31/2022 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 75,000 | $1.7M | 3/30/2022 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 365,000 | $7.9M | 3/29/2022 |
| David Henry Mack | ▲ Buy | Option Exercise | 20,000 | $27K | 3/8/2022 |
| Winston Kung | ▼ Sell | Gift | 2,725 | $0 | 12/30/2021 |
| David Henry Mack | ▲ Buy | Option Exercise | 9,000 | $5K | 12/15/2021 |
| David Henry Mack | ▼ Sell | Gift | 40,000 | $0 | 12/9/2021 |
| David Henry Mack | ▼ Sell | Gift | 40,000 | $0 | 12/9/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 800 | $24K | 10/6/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 100 | $3K | 10/4/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 11,541 | $347K | 10/1/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 2,978 | $89K | 9/30/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 5,708 | $171K | 9/29/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 1,753 | $53K | 9/27/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 100 | $3K | 9/22/2021 |
| LEVINE ARNOLD J | ▼ Sell | Open Market | 3,500 | $105K | 9/22/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 711 | $21K | 9/17/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 13,272 | $401K | 9/13/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 38,056 | $1.2M | 9/10/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 5,171 | $160K | 9/10/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 14,329 | $434K | 9/9/2021 |
| Leila Alland | ▲ Buy | Option Exercise | 100 | $390 | 9/9/2021 |
| Leila Alland | ▼ Sell | Open Market | 100 | $3K | 9/9/2021 |
| Leila Alland | ▲ Buy | Option Exercise | 3,900 | $15K | 9/7/2021 |
| Leila Alland | ▼ Sell | Open Market | 3,900 | $118K | 9/7/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 5,400 | $163K | 9/2/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 21,986 | $668K | 9/1/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 19,520 | $588K | 8/31/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 13,233 | $398K | 8/30/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 23,397 | $714K | 8/27/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 1,045 | $32K | 8/27/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 15,063 | $458K | 8/26/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 6,091 | $190K | 8/26/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 13,526 | $419K | 8/25/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 14,490 | $450K | 8/24/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 23,138 | $709K | 8/23/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 700 | $22K | 8/23/2021 |
| LEVINE ARNOLD J | ▼ Sell | Open Market | 3,500 | $103K | 8/23/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 3,800 | $118K | 8/19/2021 |
| David Henry Mack | ▲ Buy | Option Exercise | 5,500 | $3K | 8/19/2021 |
| Winston Kung | ▲ Buy | Option Exercise | 5,000 | $16K | 8/19/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 11,431 | $372K | 8/18/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 13,196 | $447K | 8/18/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 2,237 | $77K | 8/18/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 15,276 | $507K | 8/17/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 15,746 | $534K | 8/17/2021 |
| Deepika Jalota | ▲ Buy | Option Exercise | 2,896 | $10K | 8/17/2021 |
| Deepika Jalota | ▼ Sell | Open Market | 2,896 | $98K | 8/17/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 19,584 | $662K | 8/16/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 2,599 | $90K | 8/16/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 1,500 | $52K | 8/13/2021 |
| Schroeder Thilo | ▼ Sell | Open Market | 25,786 | $882K | 8/13/2021 |
| David Henry Mack | ▼ Sell | Gift | 40,000 | $0 | 3/9/2021 |
| David Henry Mack | ▼ Sell | Gift | 40,000 | $0 | 3/9/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
PMV Pharmaceuticals Adds Matt Eckler to Board
PMV Pharmaceuticals has appointed Matt Eckler, Ph.D., to its Board of Directors. This corporate update adds to the company's leadership team. The stock is currently trading near the top of its 52-week range, with an RSI of 69.0 indicating strong recent momentum.
PMV Pharmaceuticals Adds Matt Eckler to Board. PMV Pharmaceuticals has appointed Matt Eckler, Ph.D., to its Board of Directors. This corporate update adds to the company's leadership team. The stock is currently trading near the top of its 52-week range, with an RSI of 69.0 indicating strong recent momentum.